Longer colonoscopy withdrawal times associated with lower cancer rate
the ONA take:
Colonoscopy withdrawal times of 6 minutes or more are associated with lower colon cancer rates, according to research by a Veterans Affairs team.
The link between colonoscopy withdrawal time and patient outcomes is already known; this study provides strong evidence to support clinical guidelines regarding colonoscopy withdrawal times. Current guidelines recommend a withdrawal time of 6 minutes or more.
In this study, data on colonoscopies performed over 6 years by 51 gastroenterologists in a large community practice were evaluated. The average withdrawal time for the practice was 8.6 minutes; however, approximately 10% of the doctors had individual averages of less than 6 minutes.
The researchers then reviewed the state’s cancer registry for colorectal cancer cases among patients who had been screened at the practice during the study period, including cancers that occurred within 5 years of the last screening.
Referred to as interval cancers, these cancers are assumed to have developed from polyps that were either not detected during the colonoscopy, or not fully removed.
The American College of Gastroenterology acknowledges that some colons can be effectively examined in less than 6 minutes, but these findings show longer colonoscopy withdrawal times correlate with lower risk for interval cancer. The researchers report that further research is needed on quality measures for this screening procedure.
Colonoscopy withdrawal times of 6 minutes or more are associated with lower colon cancer rates.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Netupitant/Palonosetron Efficacious for Prevention of N/V in Patients Receiving MEC or HEC
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|